Evidence map›Paper›PMID 15520258›Full record

ArticleGenetics2005

Haplotype analysis of the beta2 adrenergic receptor gene and risk of myocardial infarction in humans.

Robert Y L Zee, Nancy R Cook, Rebecca Reynolds, Suzanne Cheng, Paul M Ridker

Open access · bronzeAbstract read
In one paragraph

Article in Genetics, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 28 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Robert Y L ZeeCenter for Cardiovascular Disease Prevention, LeDucq Center for Molecular and Genetic Epidemiology, Harvard Medical School, Boston, Massachusetts 02215, USA. rzee@rics.bwh.harvard.edu
Nancy R Cook
Rebecca Reynolds
Suzanne Cheng
Paul M Ridker
Brigham and Women's Hospital · USBayer (United States) · USGeneTrace Systems (United States) · USHarvard University · US

Funding

THROMBOTIC, INFLAMMATORY &GENE MARKERS OF CVD IN WOMENR01HL063293 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI RIDKER, PAUL M. · 1999 to 2002
$1.4M
INFLAMMATION, INFECTION AND FUTURE CARDIOVASCULAR RISKR01HL058755 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI RIDKER, PAUL M. · 1998 to 2000
$174k
NHLBI NIH HHS HL-58755NHLBI NIH HHS HL-63293
6 · The paper itself

Abstract

Polymorphisms in the beta2 adrenergic receptor (ADRB2), in particular G16R, Q27E, and T164I, have been implicated in the pathogenesis of cardiovascular and metabolic phenotypes. However, no prospective, genetic-epidemiological data are available on the risk of cardiovascular disease associated with these variants. Using DNA samples collected at baseline in a prospective cohort of 14,916 initially healthy American men, we evaluated the G16R, Q27E, and T164I polymorphisms among 523 individuals who subsequently developed myocardial infarction and among 2092 individuals who remained free of reported cardiovascular events during follow-up. The haplotype frequency distribution was significantly different among cases and controls (chi(2)(7d.f.) = 20.92, P = 0.0039). Haplotype-based logistic regression, adjusting for age, smoking, and randomized treatment group, indicated that G16-Q27-I164 (odds ratio 0.178, 95% C.I. 0.043-0.737, P = 0.017) and (non-G16-Q27)-T164 (odds ratio 1.235, 95% C.I. 1.031-1.480, P = 0.022) haplotypes were significantly associated with altered risk of myocardial infarction. These findings remained after further adjustment for BMI, history of hypertension, and presence or absence of diabetes. In conclusion, variation in haplotype frequencies for the beta2 adrenergic receptor gene was found to be associated with risk of myocardial infarction.

Indexed as

Polymorphism, Single NucleotideCohort StudiesGene FrequencyGenetic VariationHaplotypesHumansLinkage DisequilibriumMaleMyocardial InfarctionOdds RatioReceptors, Adrenergic, beta-2Risk FactorsUnited StatesReceptors, Adrenergic, beta-2

Identifiers

PMID15520258
PMCPMC1449541
OpenAlexW2104901181

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.